Short Interest Don’t Lie: Is CTD HOLDINGS INCORPORATED (OTCMKTS:CTDH)’s Fuel Running Low? Reports Show More Sellers

November 30, 2016 - By Hazel Jackson   ·   0 Comments

Short Interest Don't Lie: Is CTD HOLDINGS INCORPORATED (OTCMKTS:CTDH)’s Fuel Running Low? Reports Show More Sellers

The stock of CTD HOLDINGS INCORPORATED (OTCMKTS:CTDH) registered an increase of 440% in short interest. CTDH’s total short interest was 2,700 shares in November as published by FINRA. Its up 440% from 500 shares, reported previously. With 31,700 shares average volume, it will take short sellers 0 days to cover their CTDH’s short positions. About 15,925 shares traded hands or 54.36% up from the average. CTD Holdings Inc (OTCMKTS:CTDH) has declined 4.55% since April 27, 2016 and is downtrending. It has underperformed by 9.77% the S&P500.

CTD Holdings, Inc. is a biotechnology company. The company has a market cap of $27.77 million. The Firm is focused on the use of cyclodextrins in drug development. It currently has negative earnings. The United States Food and Drugs Administration has accepted the Type II Drug Master File for its lead drug candidate, Trappsol Cyclo , for filing, as a treatment for Neimann-Pick Type C disease (NPC).

CTDH Company Profile

CTD Holdings, Inc., incorporated on August 9, 1990, is a biotechnology company. The Firm is focused on the use of cyclodextrins in drug development. The United States Food and Drugs Administration has accepted the Type II Drug Master File for its lead drug candidate, Trappsol Cyclo (hydroxypropyl beta cyclodextrin), for filing, as a treatment for Neimann-Pick Type C disease (NPC). NPC is a fatal cholesterol metabolism disease found primarily in children and young adults. The Firm also sells cyclodextrins and related products to the pharmaceutical, nutritional and other industries, primarily for use in diagnostics and specialty drugs.

More notable recent CTD Holdings Inc (OTCMKTS:CTDH) news were published by: Marketwired.com which released: “CTD Holdings to Present at Niemann-Pick UK Workshop and Family Conference” on July 18, 2016, also Marketwired.com with their article: “CTD Holdings Announces FDA Acceptance of Investigational New Drug Application …” published on September 06, 2016, Marketwired.com published: “CTD Holdings Lead Director Markus W. Sieger Named CEO of Polpharma” on June 13, 2016. More interesting news about CTD Holdings Inc (OTCMKTS:CTDH) were released by: Marketwired.com and their article: “CTD Holdings Expands Family and Physicians Listening Circle on NPC” published on June 24, 2016 as well as Marketwired.com‘s news article titled: “CTD Holdings’ Clinical Program to Move Forward in the U.S.” with publication date: February 29, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By Hazel Jackson


Readers Comments (0)





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>